Population genomics and new tools for the endgame of onchocerciasis elimination in africa

Ended Project Grant Awarded Last action

Award ID
R01AI144161
Recipient
Awarding agency
Obligated
$6,591,194

Award facts

Assistance listing
93.855 Allergy and Infectious Diseases Research
Completion date
Originally
Funding
  • $5,918,303.18 Federal
  • $672,891.00 Non-federal
Place of performance
Missouri, USA

Award details come from USAspending.gov.

Transactions

Action Federal Non-federal Date
Amendment -$1 $0
Amendment $614,567 $0
Amendment $0 $0
Amendment $0 $0
Amendment $646,373 $0
Amendment $646,373 $0
Amendment $646,373 $0
Amendment $654,676 $0
Amendment $654,676 $0
Amendment $672,891 $0
Amendment $672,891 $672,891
Original award $709,484 $0
Show all 12

Subawards

Subrecipient Amount Awarded
La Trobe University Scope of work: Dr. Grant’s team 2024/25 Dr. Grant’s team will be responsible for managing interaction with the organizations and collaborators from whom O.… $1,113,744
Texas Biomedical Research Institute Scope of Work Summary The success of Community Directed Treatment with Ivermectin (CDTI) in the Americas and Africa has led to a target of eliminating infection… $254,786

Quick answers

Who received award R01AI144161?

R01AI144161 was awarded to The Washington University by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on December 1, 2019.

How much is award R01AI144161 worth?

$6,591,194 has been obligated on R01AI144161: $5,918,303 in federal funding and $672,891 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login